Health ❯ Healthcare

Weight Management

Obesity Medications Obesity Treatment Weight Loss Weight Loss Drugs Obesity Treatments Weight Loss Treatments Weight Loss Medications Pharmaceuticals Dieting

Lilly’s Oral GLP-1 Orforglipron Tops Oral Semaglutide in Lancet Phase 3 Diabetes Trial

The once-daily small-molecule pill can be taken without empty-stomach restrictions.

GLP‑1 Use Under Scrutiny After Study on Tolerability and Delhi OTC Sales

Serena Williams’ Super Bowl Ro Ad Promotes GLP-1 Weight Loss, Draws Backlash

UK Regulator Adds Rare Vision‑Loss Warning to Ozempic, Wegovy and Rybelsus

UK Regulator Flags Rare Pancreatitis, Including Deaths, Tied to Wegovy and Mounjaro

UK Regulator Adds Severe Pancreatitis Warning to Ozempic, Wegovy and Mounjaro

Roche’s CT-388 Shows Up to 22.5% Placebo-Adjusted Weight Loss in Phase 2 as Phase 3 Nears

Survey Finds 39% of UK Private Weight-Loss Jab Users in Debt

New Review Finds Rapid Weight Return After Stopping GLP-1 Weight-Loss Drugs

Trump Cites 'Very Fat' Friend's Ozempic Story to Decry Price Gap

Wegovy Pill Posts Strong U.S. Debut as U.K. Authorizes Higher 7.2 mg Injectable Dose

FDA Seeks Removal of Suicide Warnings From Saxenda, Wegovy and Zepbound

BMJ Review Flags Rapid Weight Regain After GLP‑1 Stop as UK Approves Higher‑Dose Wegovy

Oxford BMJ Review Finds Rapid Weight Rebound After Stopping Modern Weight-Loss Drugs

Weight Returns Quickly After Stopping GLP-1 Drugs, Oxford Review Finds

Trump Says He Hasn’t Taken GLP-1 Weight-Loss Drugs, ‘Probably Should’

Andy Cohen Denies Plastic Surgery After NYE Broadcast, Says He’s ‘Flattered’ by Speculation

MHRA Issues New Year Warning Against Buying Weight-Loss Jabs From Unregulated Sellers

Lilly Files Orforglipron Obesity Pill With FDA After Trial Shows Weight-Loss Maintenance

Novo Nordisk Launches Ozempic in India With Weekly Starting Price of ₹2,200